HIS and the Cruel Irony of the Weak Yen — Who Is Selling Japan Travel Now?
HIS built its empire on cheap overseas travel for Japan's youth. Now the world wants to visit Japan — and the tickets are being sold by Klook, Viator, and KKday.
HIS built its empire on cheap overseas travel for Japan's youth. Now the world wants to visit Japan — and the tickets are being sold by Klook, Viator, and KKday.
ANYCOLOR's stock has fallen 49% from its 52-week high following a full-year guidance cut tied to merchandise inventory losses. We examine the real cause, test the VC-selling hypothesis, and assess what the stumble reveals about a young management team — and why that cuts both ways.
What did Europe's auto industry lose by going all-in on EVs and selling stakes to foreign capital? Technology only lives when it is used continuously. Once severed, it cannot easily be restarted. A company is not a box — it is the accumulated knowledge, people, and history inside it.
Honda's EV retreat and up to ¥2.5tn in charges raise a deeper question: were EVs ever what consumers actually wanted? A comparison of Toyota, Honda, Nissan, and Suzuki reveals a simple truth about markets.
Kumiai Chemical (TSE:4996) posted Q1 FY2026 revenue of JPY 46.7bn (+7.7%) and operating profit of JPY 4.99bn (+24.5%), with a 10.7% operating margin. An agricultural chemicals company whose profit grows faster than revenue is executing a mix-shift toward higher-margin products — in a market where global food security concerns are elevating the value of crop protection at precisely the right moment.
Besterra (TSE:1433) posted Q3 cumulative operating profit up 98.3% year-over-year to JPY 741M on revenue of JPY 11.1bn (+2.2%). The near-doubling of operating profit on modest revenue growth, alongside an equity ratio that jumped from 43.9% to 64.8%, marks a structural turnaround for a specialist in plant demolition — a business that sits precisely at the intersection of Japan's aging industrial infrastructure and its decarbonization investment cycle.
Morozoff (TSE:2217) posted Q3 cumulative revenue of JPY 36.3bn (+0.7%) while operating profit collapsed 38.6% and net profit fell 54.6%. The company faces a version of the affordability trap in reverse — it is a premium brand that cannot easily raise prices without losing its positioning, while input costs surge on the back of global cocoa prices hitting historic highs.
Trichemical Research Institute (TSE:4369) posted Q3 cumulative revenue of JPY 23.9bn (+26.3%) and operating profit of JPY 5.90bn (+12.3%), with a 24.7% operating margin. The company makes the ultra-high-purity chemical precursors that semiconductor fabs cannot operate without — a position that places it structurally upstream of the AI infrastructure boom, largely invisible to investors focused on chip designers and equipment makers.
Kamakura Shinsyo (TSE:6184) posted Q3 cumulative revenue of JPY 8.34bn (+18.0%) and operating profit of JPY 1.16bn (+27.6%), with a 13.9% operating margin. The company operates Japan's dominant end-of-life digital platform — funeral discovery, inheritance consulting, estate real estate — in a market defined by demographic certainty: Japan records approximately 1.6 million deaths per year, a number that will only rise.
Kobe Bussan (TSE:3038) posted Q1 FY2026 revenue of JPY 141.6bn (+6.9%) and operating profit of JPY 10.9bn (+19.6%). While ordinary income fell 43.5% on one-time items, the core business tells a different story — one of a discount bulk retailer that benefits structurally from the same inflation that is squeezing peers like Kura Sushi.